Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors

A composition having BACE 1 inhibitory activity containing a compound represented by the general formula (I): wherein ring A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; E is lower alkylene; X is S, O, or NR 1 ; R 1 is a hydrogen atom or lower alkyl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ITOH, NAOHIRO, SUZUKI, SHINJI, YASUI, KEN, KOBAYASHI, NAOTAKE, YUKIMASA, AKIRA, KANDA, YASUHIKO, UEDA, KAZUO, SAKAGUCHI, GAKU, KORIYAMA, YUJI, HORI, AKIHIRO, KATO, AKIRA, HARAGUCHI, HIDEKAZU
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ITOH, NAOHIRO
SUZUKI, SHINJI
YASUI, KEN
KOBAYASHI, NAOTAKE
YUKIMASA, AKIRA
KANDA, YASUHIKO
UEDA, KAZUO
SAKAGUCHI, GAKU
KORIYAMA, YUJI
HORI, AKIHIRO
KATO, AKIRA
HARAGUCHI, HIDEKAZU
description A composition having BACE 1 inhibitory activity containing a compound represented by the general formula (I): wherein ring A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; E is lower alkylene; X is S, O, or NR 1 ; R 1 is a hydrogen atom or lower alkyl; R 2a , R 2b , R 3a , R 3b , R 4a and R 4b is each independently a hydrogen atom, halogen, or hydroxy etc.; n and m are each independently an integer of 0 to 3; n+m is an integer of 0 to 3; R 5 is a hydrogen atom or substituted lower alkyl; its pharmaceutically acceptable salt, or a solvate thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2597087B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2597087B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2597087B13</originalsourceid><addsrcrecordid>eNrjZPBwycyoTCnKz69IrMrMS1VIzEtRKEktKUoEixZUFmXmZqaAJFJSizLLEksyy1KLFRKLFZwcnV0VDBUy8zIykzJL8ouKeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAkamluYGFuZOhMRFKAHwxNDo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors</title><source>esp@cenet</source><creator>ITOH, NAOHIRO ; SUZUKI, SHINJI ; YASUI, KEN ; KOBAYASHI, NAOTAKE ; YUKIMASA, AKIRA ; KANDA, YASUHIKO ; UEDA, KAZUO ; SAKAGUCHI, GAKU ; KORIYAMA, YUJI ; HORI, AKIHIRO ; KATO, AKIRA ; HARAGUCHI, HIDEKAZU</creator><creatorcontrib>ITOH, NAOHIRO ; SUZUKI, SHINJI ; YASUI, KEN ; KOBAYASHI, NAOTAKE ; YUKIMASA, AKIRA ; KANDA, YASUHIKO ; UEDA, KAZUO ; SAKAGUCHI, GAKU ; KORIYAMA, YUJI ; HORI, AKIHIRO ; KATO, AKIRA ; HARAGUCHI, HIDEKAZU</creatorcontrib><description>A composition having BACE 1 inhibitory activity containing a compound represented by the general formula (I): wherein ring A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; E is lower alkylene; X is S, O, or NR 1 ; R 1 is a hydrogen atom or lower alkyl; R 2a , R 2b , R 3a , R 3b , R 4a and R 4b is each independently a hydrogen atom, halogen, or hydroxy etc.; n and m are each independently an integer of 0 to 3; n+m is an integer of 0 to 3; R 5 is a hydrogen atom or substituted lower alkyl; its pharmaceutically acceptable salt, or a solvate thereof.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160330&amp;DB=EPODOC&amp;CC=EP&amp;NR=2597087B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160330&amp;DB=EPODOC&amp;CC=EP&amp;NR=2597087B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ITOH, NAOHIRO</creatorcontrib><creatorcontrib>SUZUKI, SHINJI</creatorcontrib><creatorcontrib>YASUI, KEN</creatorcontrib><creatorcontrib>KOBAYASHI, NAOTAKE</creatorcontrib><creatorcontrib>YUKIMASA, AKIRA</creatorcontrib><creatorcontrib>KANDA, YASUHIKO</creatorcontrib><creatorcontrib>UEDA, KAZUO</creatorcontrib><creatorcontrib>SAKAGUCHI, GAKU</creatorcontrib><creatorcontrib>KORIYAMA, YUJI</creatorcontrib><creatorcontrib>HORI, AKIHIRO</creatorcontrib><creatorcontrib>KATO, AKIRA</creatorcontrib><creatorcontrib>HARAGUCHI, HIDEKAZU</creatorcontrib><title>Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors</title><description>A composition having BACE 1 inhibitory activity containing a compound represented by the general formula (I): wherein ring A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; E is lower alkylene; X is S, O, or NR 1 ; R 1 is a hydrogen atom or lower alkyl; R 2a , R 2b , R 3a , R 3b , R 4a and R 4b is each independently a hydrogen atom, halogen, or hydroxy etc.; n and m are each independently an integer of 0 to 3; n+m is an integer of 0 to 3; R 5 is a hydrogen atom or substituted lower alkyl; its pharmaceutically acceptable salt, or a solvate thereof.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZPBwycyoTCnKz69IrMrMS1VIzEtRKEktKUoEixZUFmXmZqaAJFJSizLLEksyy1KLFRKLFZwcnV0VDBUy8zIykzJL8ouKeRhY0xJzilN5oTQ3g4Kba4izh25qQX58anFBYnJqXmpJvGuAkamluYGFuZOhMRFKAHwxNDo</recordid><startdate>20160330</startdate><enddate>20160330</enddate><creator>ITOH, NAOHIRO</creator><creator>SUZUKI, SHINJI</creator><creator>YASUI, KEN</creator><creator>KOBAYASHI, NAOTAKE</creator><creator>YUKIMASA, AKIRA</creator><creator>KANDA, YASUHIKO</creator><creator>UEDA, KAZUO</creator><creator>SAKAGUCHI, GAKU</creator><creator>KORIYAMA, YUJI</creator><creator>HORI, AKIHIRO</creator><creator>KATO, AKIRA</creator><creator>HARAGUCHI, HIDEKAZU</creator><scope>EVB</scope></search><sort><creationdate>20160330</creationdate><title>Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors</title><author>ITOH, NAOHIRO ; SUZUKI, SHINJI ; YASUI, KEN ; KOBAYASHI, NAOTAKE ; YUKIMASA, AKIRA ; KANDA, YASUHIKO ; UEDA, KAZUO ; SAKAGUCHI, GAKU ; KORIYAMA, YUJI ; HORI, AKIHIRO ; KATO, AKIRA ; HARAGUCHI, HIDEKAZU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2597087B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ITOH, NAOHIRO</creatorcontrib><creatorcontrib>SUZUKI, SHINJI</creatorcontrib><creatorcontrib>YASUI, KEN</creatorcontrib><creatorcontrib>KOBAYASHI, NAOTAKE</creatorcontrib><creatorcontrib>YUKIMASA, AKIRA</creatorcontrib><creatorcontrib>KANDA, YASUHIKO</creatorcontrib><creatorcontrib>UEDA, KAZUO</creatorcontrib><creatorcontrib>SAKAGUCHI, GAKU</creatorcontrib><creatorcontrib>KORIYAMA, YUJI</creatorcontrib><creatorcontrib>HORI, AKIHIRO</creatorcontrib><creatorcontrib>KATO, AKIRA</creatorcontrib><creatorcontrib>HARAGUCHI, HIDEKAZU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ITOH, NAOHIRO</au><au>SUZUKI, SHINJI</au><au>YASUI, KEN</au><au>KOBAYASHI, NAOTAKE</au><au>YUKIMASA, AKIRA</au><au>KANDA, YASUHIKO</au><au>UEDA, KAZUO</au><au>SAKAGUCHI, GAKU</au><au>KORIYAMA, YUJI</au><au>HORI, AKIHIRO</au><au>KATO, AKIRA</au><au>HARAGUCHI, HIDEKAZU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors</title><date>2016-03-30</date><risdate>2016</risdate><abstract>A composition having BACE 1 inhibitory activity containing a compound represented by the general formula (I): wherein ring A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group; E is lower alkylene; X is S, O, or NR 1 ; R 1 is a hydrogen atom or lower alkyl; R 2a , R 2b , R 3a , R 3b , R 4a and R 4b is each independently a hydrogen atom, halogen, or hydroxy etc.; n and m are each independently an integer of 0 to 3; n+m is an integer of 0 to 3; R 5 is a hydrogen atom or substituted lower alkyl; its pharmaceutically acceptable salt, or a solvate thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2597087B1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Dihydrooxazine and tetrahydropyrimidine derivatives as BACE 1 inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T16%3A52%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ITOH,%20NAOHIRO&rft.date=2016-03-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2597087B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true